Skip to the page

Data / Federal rules / 2024-15136

Advisory Committee; Allergenic Products Advisory Committee; Termination; Removal From List of Standing Committees

The Food and Drug Administration published this final rule in the Federal Register on July 10, 2024. It took effect on July 10, 2024.

SpecStream is the live web data engine for teams and agents. It reads every rule and proposed rule in the Federal Register each morning, and this page is that reading. Name your industry once and new rules, comment deadlines and effective dates arrive in your sheet, CRM, Slack or agent as they are published.

What the agency says

The Food and Drug Administration (FDA or Agency) is announcing the termination of the Allergenic Products Advisory Committee, Center for Biologics Evaluation and Research. This document announces the reasons for termination and removes the Allergenic Products Advisory Committee from the Agency's list of standing advisory committees.

Key facts

Document number
2024-15136
Type
Final rule
Action
Final rule
Agency
Health and Human Services Department; Food and Drug Administration
Published
July 10, 2024
Takes effect
July 10, 2024
Dates
This rule is effective July 10, 2024.
Docket
Docket No. FDA-2024-N-3008
Code of Federal Regulations
21 CFR 14
Topics
Administrative practice and procedure; Advisory committees; Color additives; Drugs; Radiation protection
Pages
2

The document on federalregister.gov PDF

Other documents from the Food and Drug Administration

Everything from the Food and Drug Administration · Rules on administrative practice and procedure · Rules on advisory committees · Rules on color additives · Published in July 2024

Read from the Federal Register API, last updated 2026-10-23. The document on federalregister.gov is the official record; dates and dockets can change through later corrections. Free to reuse with credit to SpecStream under CC BY 4.0.